“…In rodent models of pain, heightened pain responses and neuroinflammation occur concurrently with enhanced excitatory synaptic transmission between the nucleus parabrachialis, basolateral nuclei of the amygdala, and the central nuclei of the amygdala (CeA) [ 116 , 117 ]. The release of neuropeptides calcitonin gene-related peptide (CGRP) [ 118 , 119 ], substance P [ 120 ], and vasopressin [ 121 , 122 , 123 ] have been reported to upregulate the excitatory, glutamatergic drive to enhance pain-related plasticity in the CeA. In contrast, neuropeptide S-, somatostatin-, and oxytocin-expressing neurons inhibit these pain-enhancing factors and downregulate nociceptive tone [ 121 , 122 , 124 , 125 ].…”